Cargando…
Evaluation of the role of erythropoietin and methotrexate in multiple sclerosis
BACKGROUND: Erythropoietin, originally recognized for its role in erythropoiesis, has been shown to improve neurological outcome after stroke. Low-dose methotrexate is effective against certain inflammatory diseases, such as severe psoriasis and rheumatoid arthritis as well as Crohn's disease....
Autores principales: | Dasgupta, Sandipan, Mazumder, Bhaskar, Ramani, Y. Roja, Bhattacharyya, Subhra Prakash, Das, Mukesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195118/ https://www.ncbi.nlm.nih.gov/pubmed/22021991 http://dx.doi.org/10.4103/0253-7613.84955 |
Ejemplares similares
-
Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation
por: Patel, Dilip, et al.
Publicado: (2012) -
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin
por: Sühs, Kurt-Wolfram, et al.
Publicado: (2016) -
Contradictory effects of erythropoietin on inhibitory synaptic transmission in left and right prelimbic cortex of mice
por: Dik, Andre, et al.
Publicado: (2018) -
Multiple Pruritic Keratotic Papules on the Extremities in a 14-Year-Old Boy
por: Srinivas, Sahana M, et al.
Publicado: (2022) -
A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
por: Nikfar, Shekoufeh, et al.
Publicado: (2010)